Category: us corporate news

us corporate news

MicuRx Pharmaceuticals: Advancing Novel ADC Therapy MICVO for Difficult-to-Treat Head and Neck Cancer – Pipeline, Strategy, and Risks Overview

Minichart

March 23, 2026

Pyxis Oncology 2025 Annual Report: Key Highlights for Invest...

Continue Reading 0

us corporate news

Arbutus Biopharma 2025 Annual Report: Clinical Pipeline, Patent Litigation, and Strategic Outlook

Minichart

March 23, 2026

Arbutus Biopharma Corp 2025 Annual Report: Key Investor High...

Continue Reading 0

us corporate news

Cabaletta Bio 2024 Annual Report: Engineered T Cell Therapies, Competitive Landscape, and Intellectual Property Strategies for Autoimmune Diseases

Minichart

March 23, 2026

Cabaletta Bio, Inc. 2025 Annual Report: Key Investor Highlig...

Continue Reading 0

us corporate news

Xilio Therapeutics: Advancing Masked Immuno-Oncology Therapies for Improved Cancer Outcomes

Minichart

March 23, 2026

Xilio Therapeutics 2025 Annual Report: Key Investor Highligh...

Continue Reading 0

us corporate news

Solo Brands, Inc. 2025 Annual Report: Business Overview, Growth Strategy, Products, and Competitive Risks

Minichart

March 23, 2026

Executive Summary Solo Brands, Inc. (NYSE: SBDS) has rele...

Continue Reading 0

us corporate news

Newbridge Acquisition Limited 2025 10-K: Business Strategy, Target Criteria, and Regulatory Risks for Emerging Markets SPACs

Minichart

March 23, 2026

Newbridge Acquisition Ltd 2025 Annual Report: Detailed Analy...

Continue Reading 0

us corporate news

Abundia Global Impact Group, Inc. Focuses on Low-Carbon Energy Solutions and Waste-to-Fuels Technology in 2025 Annual Report

Minichart

March 23, 2026

Abundia Global Impact Group, Inc. (AGIG) 2025 Annual Report:...

Continue Reading 0

us corporate news

Theravance Biopharma 2025 Annual Report: YUPELRI Commercialization, Strategic Review, and Organizational Restructuring

Minichart

March 23, 2026

Theravance Biopharma, Inc. (TBPH) 2025 Annual Report – Key I...

Continue Reading 0

us corporate news

Bally’s Corporation 2025 10-K: Business Segments, Acquisitions, and Financial Reporting Overview

Minichart

March 23, 2026

Financial Report Analysis: Key Investor Insights from Bally'...

Continue Reading 0

us corporate news

MAIA Biotechnology, Inc. 2025 Annual 10-K SEC Filing Overview: Private Placements, Warrants, and Equity Transactions

Minichart

March 23, 2026

MAIA Biotechnology, Inc. 2025 Annual Report: Key Highlights ...

Continue Reading 0